Article
Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis.
Science (New York, N.Y.) - 16 Sept 2011
Shi Wanliang, Zhang Xuelian, Jiang Xin, Yuan Haiming, Lee Jong Seok, Barry Clifton E, Wang Honghai, Zhang Wenhong, Zhang Ying
Abstract excerpt
Pyrazinamide (PZA) is a first-line tuberculosis drug that plays a unique role in shortening the duration of tuberculosis chemotherapy. PZA is hydrolyzed intracellularly to pyrazinoic acid (POA) by pyrazinamidase (PZase, encoded by pncA), an enzyme frequently lost in PZA-resistant strains, but the target of POA in Mycobacterium tuberculosis has remained elusive. Here, we identify a previously unknown target of POA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
